3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
34
Rectal Neoplasms
22
Triple Negative Breast Neoplasms
16
Stomach Neoplasms
16
Colorectal Neoplasms
13
Neoplasm Metastasis
9
Adenocarcinoma
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
7
Neoplasms
5
Nasopharyngeal Carcinoma
5
Biliary Tract Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Carcinoma
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Resectable Colon Cancer
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Sunitinib
2
Everolimus
2
sargramostim
1
montanide ISA 51
1
lutetium Lu 177 dotatate
1
lanreotide
1
incomplete Freund's adjuvant
1
fludarabine phosphate
1
cabozantinib
1
belzutifan
1
X-Rays
1
Temozolomide
1
Phantoms, Imaging
1
Octreotide
1
Methods
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Blood Specimen Collection
1
Biopsy
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
Capecitabine
×
90 days
×
Clear all
No trials found.